Are you a Stanford student interested in ETL and MS&E 472? If so, check out our FAQ!

The Evolution of Biotech

George Scangos, Vir Biotechnology
With Jody Puglisi, Stanford School of Medicine

George Scangos, president and CEO of Vir Biotechnology, describes how the biotech industry has changed over the past several decades. Advances in both the speed of genetic research and the capabilities of data science, as well as some prominent successes, he finds, have accelerated biotech investments and innovation.